Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Engelfriet

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Vox Sanguinis|August 6, 1998
Consequences of nucleic acid amplification testing for blood transfusion centresH W Reesink, C P Engelfriet, H Vrielink, et al.
Vox Sanguinis|January 1, 1997
Management of alloimmunized, refractory patients in need of platelet transfusionsC P Engelfriet, H W Reesink, R H Aster, et al.
Vox Sanguinis|May 31, 2001
Red cell transfusions in neonatal careC P Engelfriet, H W Reesink, R G Strauss, et al.
Vox Sanguinis|July 9, 2002
Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?H W Reesink, C P Engelfriet, G E Tegtmeier, et al.
Vox Sanguinis|November 30, 1999
Haemovigilance systemsC P Engelfriet, H W Reesink, B Brand, et al.
Vox Sanguinis|June 6, 2000
The detection of alloantibodies against red cells in patients with warm-type autoimmune haemolytic anaemiaC P Engelfriet, H W Reesink, G Garratty, et al.
Vox Sanguinis|June 26, 2003
The future use of pathogen-inactivated platelet concentratesC P Engelfriet, H W Reesink, H G Klein, et al.
Vox Sanguinis|August 20, 2003
Future counselling of donors and recipients of blood products concerning prion-related diseasesH W Reesink, C P Engelfriet, L Muylle, et al.
Vox Sanguinis|January 6, 2009
Neonatal transfusionsH V New, S J Stanworth, C P Engelfriet, et al.
Vox Sanguinis|January 14, 2009
Cord blood bankingA Brand, P Rebulla, C P Engelfriet, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Vox Sanguinis|August 6, 1998
Consequences of nucleic acid amplification testing for blood transfusion centresH W Reesink, C P Engelfriet, H Vrielink, et al.
Vox Sanguinis|January 1, 1997
Management of alloimmunized, refractory patients in need of platelet transfusionsC P Engelfriet, H W Reesink, R H Aster, et al.
Vox Sanguinis|May 31, 2001
Red cell transfusions in neonatal careC P Engelfriet, H W Reesink, R G Strauss, et al.
Vox Sanguinis|July 9, 2002
Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?H W Reesink, C P Engelfriet, G E Tegtmeier, et al.
Vox Sanguinis|November 30, 1999
Haemovigilance systemsC P Engelfriet, H W Reesink, B Brand, et al.
Vox Sanguinis|June 6, 2000
The detection of alloantibodies against red cells in patients with warm-type autoimmune haemolytic anaemiaC P Engelfriet, H W Reesink, G Garratty, et al.
Vox Sanguinis|June 26, 2003
The future use of pathogen-inactivated platelet concentratesC P Engelfriet, H W Reesink, H G Klein, et al.
Vox Sanguinis|August 20, 2003
Future counselling of donors and recipients of blood products concerning prion-related diseasesH W Reesink, C P Engelfriet, L Muylle, et al.
Vox Sanguinis|January 6, 2009
Neonatal transfusionsH V New, S J Stanworth, C P Engelfriet, et al.
Vox Sanguinis|January 14, 2009
Cord blood bankingA Brand, P Rebulla, C P Engelfriet, et al.
Pageof 18